Thermo Fisher Scientific Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript

Jun 10, 2021 / 01:40PM GMT
Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Good morning, everyone. This is Matt Sykes from Goldman Sachs. Apologies for the technical difficulties here, but I have the pleasure of introducing Marc Casper from Thermo Fisher, the Chairman, President and Chief Executive Officer. Marc, thank you very much for joining us. We appreciate your time today.

Marc N. Casper - Thermo Fisher Scientific Inc. - Chairman, President & CEO

Great to be here, Matt. Thanks, thanks for hosting.

Questions and Answers:

Matthew Carlisle Sykes - Goldman Sachs Group, Inc., Research Division - Research Analyst

Great. Maybe I thought I kind of let you set the stage for us for the first few minutes. And maybe spend some time on what we think is the sort of the key question that we've been receiving from investors. And that's what does Thermo look like in a post-COVID environment? Will it be a faster-growing and higher-margin company post-COVID versus pre-COVID? And how can investors frame
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot